Article · 26 Jun 2024
Mini reviewPublished 29 Sep 2022
Current Developments and Challenges in Nanoparticles for Cancer Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Malignant growth is caused because of the unregulated expansion of cells. Figuring out the distinctions between a malignant growth cell and a typical cell; an ordinary tissue and a cancer microenvironment is the way to fostering a productive designated drug conveyance framework for disease treatment. With ongoing improvements in malignant growth cell science, materials science and nanotechnology a ton of new techniques have been laid out for dynamic cancer designated drug conveyance. With the assistance of nanocarriers, conveying the ideal portion of mixes of anticancer medications explicitly inside the cytoplasm of malignant growth cells is presently conceivable. Furthermore, inorganic and natural selfrestorative nanomaterials have been created. They are nanoparticles comprised of materials with anticancer action. This survey article explains on the hindrances in malignant growth treatment and the new advancements to beat those obstructions with various present day nanocarriers and self-restorative nanomaterials.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2015
Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer
Conference abstract · 2016
Development and evaluation of a tri-functional lipid nanoparticles for treatment of HER2- Positive breast cancer refractory to HER2 therapy
Conference abstract · 18 Jul 2018
An overview on the recent developments made in anti-cancer drug therapy and origin of gold nanoparticles as a valuable resource
Review article · 7 Jun 2021
Clinical Challenges to Current Molecularly Targeted Therapies in CellularBreakdown in the Lungs
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Dipanjan Das”

